Does omitting the clinical target volume in stereotactic radiotherapy for NSCLC affect oncologic outcomes? A retrospective analysis
Omitting CTV margins in lung-SBRT may compromise LC when rCTV coverage with BED ≥100 Gy is insufficient, warranting further investigation into the clinical benefit of adding CTV margins.
Authors
- Daniel Schmidhalter (ORCID: https://orcid.org/0000-0001-9914-6728)
- Ilya Kotov (ORCID: https://orcid.org/0000-0001-6360-0300)
- Philipp Reinhardt (ORCID: https://orcid.org/0000-0003-3951-9275)
- Daniel H. Schanne (ORCID: https://orcid.org/0000-0001-5189-0507)
- Olgun Eliçin (ORCID: https://orcid.org/0000-0002-6996-0646)
- Dora Correia (ORCID: https://orcid.org/0000-0003-1099-9009)
Institutions
- University of Bern (CH)
- University Hospital of Bern (CH)
- Kantonsspital Aarau (CH)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2025-08-10
- DOI
- https://doi.org/10.1016/j.radonc.2025.111092
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52